"Highly accessible and sprightly written."-Library Journal Winner of the Kansas State Library's Kansas Notable Book Award In this engaging, fast-paced biography, Louis Galambos follows the career of Dwight D. "Ike" Eisenhower, offering new insight into this singular man who guided America toward consensus at home and a peaceful victory in the Cold War. The longtime editor of the Eisenhower papers, Galambos may know more about this president than anyone alive. In this compelling book, he explores the shifts in Eisenhower's identity and reputation over his lifetime and explains how he developed his distinctive leadership skills. As a career military officer, Eisenhower's progress was uneven. Galambos shows how Ike, with the help of Brigadier General Fox Conner, his mentor and patron, learned how to profit from his mistakes, pivot quickly, and grow as a military and civilian leader. On D-Day, Eisenhower guided the largest amphibious force in history to a successful invasion of France and a decisive victory. After the defeat of Nazi Germany, he turned to politics and was elected president in 1952. While today's fiercely partisan political climate makes it difficult to imagine a president forging consensus in Washington, that's exactly what Eisenhower did. As America's leader in an era of profound postwar changes at home and abroad, President Eisenhower sought a middle way with compromise and coalition building. He provided his country with firm-handed leadership, bringing prosperity and peace to the American people in the dangerous years of the Cold War-an accomplishment that made him one of the most influential men of the twentieth century. Destined to be the best short biography of the thirty-fourth president of the United States, Eisenhower conclusively demonstrates how and why this master of the middle way became the successful leader of the free world.

"Highly accessible and sprightly written."-Library Journal Winner of the Kansas State Library's Kansas Notable Book Award In this engaging, fast-paced biography, Louis Galambos follows the career of Dwight D. "Ike" Eisenhower, offering new insight into this singular man who guided America toward consensus at home and a peaceful victory in the Cold War. The longtime editor of the Eisenhower papers, Galambos may know more about this president than anyone alive. In this compelling book, he explores the shifts in Eisenhower's identity and reputation over his lifetime and explains how he developed his distinctive leadership skills. As a career military officer, Eisenhower's progress was uneven. Galambos shows how Ike, with the help of Brigadier General Fox Conner, his mentor and patron, learned how to profit from his mistakes, pivot quickly, and grow as a military and civilian leader. On D-Day, Eisenhower guided the largest amphibious force in history to a successful invasion of France and a decisive victory. After the defeat of Nazi Germany, he turned to politics and was elected president in 1952. While today's fiercely partisan political climate makes it difficult to imagine a president forging consensus in Washington, that's exactly what Eisenhower did. As America's leader in an era of profound postwar changes at home and abroad, President Eisenhower sought a middle way with compromise and coalition building. He provided his country with firm-handed leadership, bringing prosperity and peace to the American people in the dangerous years of the Cold War-an accomplishment that made him one of the most influential men of the twentieth century. Destined to be the best short biography of the thirty-fourth president of the United States, Eisenhower conclusively demonstrates how and why this master of the middle way became the successful leader of the free world.

Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded.

How can countries chart their own course toward universal health coverage? Like many ambitious global goals, universal health coverage (UHC) remains an aspiration for many countries. The World Health Organization estimates that half the world's population lacks access to basic health services. Moreover, this already staggering number masks inequities that exist between and within countries: gaps between rich and poor, men and women, young and old, and among people of different ethnic backgrounds. UHC promises to give all people greater access to higher quality health services without the fear of financial hardship. But the task of turning this vision into reality poses a significant challenge for countries at all stages of economic development. In The Road to Universal Health Coverage, Jeffrey L. Sturchio, Ilona Kickbusch, Louis Galambos, and their contributors explore the ways in which the private sector is already helping countries achieve universal health coverage. Stressing the many positive aspects of UHC developments, the book focuses on the new health economy and the sometimes controversial dimensions of the private sector helping countries achieve UHC. Theoretical chapters are complemented by a series of case studies that explore the myriad ways in which private sector actors are already addressing UHC. What are the conditions required for countries to translate their successful experiences and policy promises into practical results for improved population health? In answering this question, the contributors examine the relationship between health employment and economic growth. They also analyze the critical success factors for private sector engagement in UHC, the role of healthy women in creating and sustaining healthy economies, and the role of the pharmaceutical sector. Looking to the political, economic, and social implications of moving from aspiration to implementation, The Road to Universal Health Coverage points the way to the many opportunities ahead as companies continue to work with governments and civil society partners to help achieve UHC. Jean-Louise Arcand, Hector Arreola-Ornelas, Nathan J. Blanchet, Christine Bugos, Jim Campbell, John Campbell, Jr., Ibadat Dhillon, Donika Dimovska, Christian Franz, Michael Furst, Louis Galambos, Belen Garijo, Adeel Ishtiaq, Sowmya Kadandale, Ilona Kickbusch, Felicia Marie Knaul, Jeremy Lauer, Robert Marten, Justin McCarthy, Harald Nusser, K. Srinath Reddy, Yasmine Rouai, Jeffrey L. Sturchio, Cicely Thomas, Tana Wuliji, Snow Yang, Pascal Zurn

Noncommunicable diseases (NCDs) - including cardiovascular disease, diabetes, asthma and other chronic respiratory conditions, and cancers - are the leading causes of death worldwide. An estimated 36 million people die from such diseases each year; this represents roughly two out of three deaths globally. Eighty percent of these fatalities occur in developing countries. The statistics are staggering, yet millions of these deaths are preventable. This is an urgent global health issue that demands analysis of gaps in NCD research, new policies and practices, and actionable recommendations to close the gaps. The Johns Hopkins Institute for Applied Economics, Global Health, and the Study of Business Enterprise convened an NCD Working Group of leading scholars to examine a wide range of issues that both the private and public sectors must address to make sustainable progress in NCD prevention and treatment in lower- and middle-income countries. Collected in this volume are essays on five key areas where strengthened policies and health systems can have the most impact in the near future. Features: accelerating regulatory harmonization; structuring supply chains; improving access to interventions; restructuring primary care; and promoting multisectoral and intersectoral action. While there is a growing literature on the problem of NCDs, none of the available studies provides background on the range of challenges matched with specific steps that can be taken by the public sector, private sector, and civil society working together. Noncommunicable Diseases in the Developing World presents a framework for understanding the salience of specific policy recommendations and detailed steps that can be taken now to move forward in the global campaign against NCDs. This book will be of interest to practitioners, scholars, and students in public health as well as those framing and implementing health policies in the private and public sectors.

Otiginally published in 1975. At the time that Louis Galambos published The Public Image of Big Business in America in 1975, America had matured into a bureaucratic state. The expression of the military-industrial complex and big business grew so pervasive that the postwar United States was defined in large part by its citizens' participation in large-scale organizational structures. Noticing this development, Galambos maintains that the "single most significant phenomenon in modern American history is the emergence of giant, complex organizations." Today, bureaucratic organizations influence the day-to-day lives of most Americans-they gather taxes, regulate businesses, provide services, administer welfare, provide education, and on and on. These organizations are defined by their hierarchical structure in which the power of decision-making is allotted according to abstract rules that create impersonal scenarios. Bureaucracies have developed as a result of technological changes in the second half of the nineteenth century. Based on the premise that these structures had a stronger influence on modern America than any other single phenomenon, this book explores the public's response to the growth of the power and influence of bureaucracy from the years 1880 through 1930. What results is an examination of the social perception of bureaucracy and the development of bureaucratic culture.

This book, first published in 2007, presents research by leading scholars to an international audience of academics, business executives, and policy makers. This research is presented in two clusters. The first cluster of studies explores four cross-cutting topics, including surveys of the changes in industry structure, corporate strategies, plant technologies, governmental policies, finance, and corporate governance. The second cluster of studies comprises nine country surveys that examine the experiences of representative nations in chemical production and foreign trade. By combining the similar historical cases of a few nations (such as Sweden, Norway, and Finland), the authors are able to deal with eleven chemical-producing nations, including all of the leaders in this area as well as some of the important followers.

The essays in this volume probe the impact the digital revolution has had, or sometimes failed to have, on global business. Has digital technology, the authors ask, led to structural changes and greater efficiency and innovation? While most of the essays support the idea that the information age has increased productivity in global business, the evidence of a 'revolution' in the ways industries are organized is somewhat more blurred, with both significant discontinuities and features which persist from the 'second' industrial revolution.

The Creative Society is the first history to look at modern America through the eyes of its emerging ranks of professional experts, including lawyers, scientists, doctors, administrators, business managers, teachers, policy specialists and urban planners. Covering the period from the 1890s to the early twenty-first century, Louis Galambos examines the history that shaped professionals and, in turn, their role in shaping modern America. He considers the roles of education, anti-Semitism, racism and elitism in shaping and defining the professional cadre and examines how matters of gender, race and ethnicity determined whether women, African Americans and immigrants from Europe, Asia, Latin America and the Middle East were admitted to the professional ranks. He also discusses the role professionals played in urbanizing the United States, keeping the economy efficient and innovative, showing the government how to provide a greater measure of security and equity, and guiding the world's leading industrial power in coping with its complex, frequently dangerous foreign relations.

Wireless entrepreneurs are transforming the way people live and work around the globe. In the process they have created some of the fastest growing companies on the planet. Anytime, Anywhere tells the story of the birth and explosion of cellular and wireless communications as seen through the eyes of one of the industry's pioneers, Sam Ginn. As deregulation and privatization swept the globe, Ginn and his team at AirTouch Communications fought for and won licenses on several continents. They built a successful business using strategic partnerships and joint ventures and demonstrated a new model for global entrepreneurship in an information-based economy. Louis Galombos is Professor of History at Johns Hopkins University. He has written numerous books and articles on entrepreneurship, innovation and regulation, including Networks of Innovation (Cambridge, 1996) and The Rise of the Corporate Commonwealth (Basic, 1989), He is President of the Business History Group. Eric Abrahamson is Principal Historian with The Prologue Group. His research has dealt with telecommunications, banking and regulation in California.

This book, first published in 2007, presents research by leading scholars to an international audience of academics, business executives, and policy makers. This research is presented in two clusters. The first cluster of studies explores four cross-cutting topics, including surveys of the changes in industry structure, corporate strategies, plant technologies, governmental policies, finance, and corporate governance. The second cluster of studies comprises nine country surveys that examine the experiences of representative nations in chemical production and foreign trade. By combining the similar historical cases of a few nations (such as Sweden, Norway, and Finland), the authors are able to deal with eleven chemical-producing nations, including all of the leaders in this area as well as some of the important followers.

Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded.

In Medicine, Science, and Merck, the authors trace the careers of a son of Greek immigrants as he mastered three professions and ultimately became the Chief Executive Officer of America’s most admired corporation - the multinational, pharmaceutical giant, Merck & Co., Inc. As the authors show, there was hope even for a wise-cracking kid living through the hard times of the 1930s. Education brought out the scholar in Roy Vagelos, who left his family’s small restaurant to attend the University of Pennsylvania, Columbia’s Medical School, and Massachusetts General Hospital in Boston. At NIH, he mastered biochemistry; at Washington University he became a distinguished science administrator; and at Merck, he headed the pharmaceutical industry’s most innovative laboratory and then became its CEO. Throughout, he never lost touch with his family values, his intense desire to help others, or his faith in the partnership principle and the competition that makes it work.

Wireless entrepreneurs are transforming the way people live and work around the globe. In the process they have created some of the fastest growing companies on the planet. Anytime, Anywhere tells the story of the birth and explosion of cellular and wireless communications as seen through the eyes of one of the industry's pioneers, Sam Ginn. As deregulation and privatization swept the globe, Ginn and his team at AirTouch Communications fought for and won licenses on several continents. They built a successful business using strategic partnerships and joint ventures and demonstrated a new model for global entrepreneurship in an information-based economy. Louis Galombos is Professor of History at Johns Hopkins University. He has written numerous books and articles on entrepreneurship, innovation and regulation, including Networks of Innovation (Cambridge, 1996) and The Rise of the Corporate Commonwealth (Basic, 1989), He is President of the Business History Group. Eric Abrahamson is Principal Historian with The Prologue Group. His research has dealt with telecommunications, banking and regulation in California.

The Creative Society is the first history to look at modern America through the eyes of its emerging ranks of professional experts, including lawyers, scientists, doctors, administrators, business managers, teachers, policy specialists and urban planners. Covering the period from the 1890s to the early twenty-first century, Louis Galambos examines the history that shaped professionals and, in turn, their role in shaping modern America. He considers the roles of education, anti-Semitism, racism and elitism in shaping and defining the professional cadre and examines how matters of gender, race and ethnicity determined whether women, African Americans and immigrants from Europe, Asia, Latin America and the Middle East were admitted to the professional ranks. He also discusses the role professionals played in urbanizing the United States, keeping the economy efficient and innovative, showing the government how to provide a greater measure of security and equity, and guiding the world's leading industrial power in coping with its complex, frequently dangerous foreign relations.

A panoramic survey of the interactions between American business and public policy, from J.P. Morgan to Lee Iacocca.

AT&T's divestiture was the largest corporate reorganization in history and has had international repercussions. It was a major development in American economic policy, and a prominent part of the deregulation movement of the late 1970s. This study reveals the internal decision-making process at AT&T and explains how private and public interests combined to shape corporate and public policy in late 20th-century America. Temin weaves the strands of politics, economics, business, and law into an accessible narrative history that will be of interest to the general reader who wants to know about government business interaction and how it affects American citizens. Temin portrays divestiture as a great experiment in public policy, competition, openness, and international policy. He concludes that the experiment has been a mix of deliberate design and uncontrollable forces whose outcome was not foreseen.

Networks of Innovation offers a historical perspective on the manner in which private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp & Dohme, which acquired Mulford in 1929, and on Merck & Co., Inc., which merged with Sharp & Dohme in 1953. By surveying a century of innovation in biologicals, the authors show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad.